Cancer Treatment Centers of America
(800) 615-3055

Have questions? Call (800) 615-3055 to speak to a cancer information specialist.

The CTCA blog

The soy debate: Is soy good for you?


The debate over the pros and cons of soy has been gaining momentum in recent years, with some touting the benefits of soy and others vehemently against the versatile bean. With all the misinformation out there, we asked Carolyn Lammersfeld, Vice President of Integrative Medicine at our Chicago-area hospital, to chime in.

$109 million pledged during Stand Up to Cancer fundraiser


Stand Up to Cancer called on some of the biggest names in Hollywood for its fundraising telecast on Sept. 5 and brought in more than $109 million in pledges for cancer research. CTCA was one of four “Visionary” donors supporting the event.

The fundraiser kicked off on the red carpet at the Dolby Theatre in Los Angeles and lasted through the evening.

CTCA patient draws on experience as a first responder to fight cancer

Eugene Hunley

When I worked as a firefighter/paramedic, fear was a constant presence. It was fear for my patients, fear for my fellow firefighters and even fear for my own life. Imagine how you would feel if you were about to walk into a 30-foot wall of fire. But fear on the job was always tempered by the support of my team.

I quickly learned the importance of having complete confidence in my fellow firefighters. Every member of my team was there to support me, whether it was at the hose, at a victim rescue, or if I went down. This is why firefighters call it a brotherhood.

Marine cone snail venom could treat chronic neuropathic pain

Raed Rahman, DO

Because many of my patients experience severe chronic neuropathic pain—a type of pain that is complex and difficult to resolve—I’m always looking for new, more effective therapies. The next big thing in pain medicine could come from a surprising source: the marine cone snail.

I read with interest a recent article in Pain Medicine News, “Studying Neuropathic Pain, at a Snail’s Pace,” that discusses the development of neuropathic pain therapies based on the marine cone snail.